PolyPid Announces 2026 Annual General Meeting and Director Nominations

PolyPid Ltd. filed a Form 6-K on June 10, 2026, announcing an Annual and Extraordinary General Meeting of Shareholders scheduled for July 15, 2026. The meeting's agenda includes the re-election of eight current board members: Dikla Czaczkes Akselbrad (CEO), Brooke Story (Chairman), Yechezkel Barenholz, Joseph BenAmram, Nir Dror, Yitzchak Jacobovitz, Itzhak Krinsky, and Robert B. Stein. In addition to director re-elections, the company is seeking shareholder approval for several compensation-related items. These include an amendment to the terms of annual option grants for non-executive directors and a specific grant of 149,000 options to CEO Dikla Czaczkes Akselbrad. The proposed options for the CEO would vest over four years with an exercise price of $4.46 per share. Shareholders will also vote on the re-appointment of Kost Forer Gabbay & Kasierer as the company's independent auditors and discuss the financial statements for the fiscal year ended December 31, 2025. The record date for voting eligibility is June 15, 2026.